Our ambition is clear: pioneer a new era in AI-powered R&D through our immunoscience-first approach. This vision depends on strategic pharmaceutical partnerships and biotech collaborations throughout the entire drug development and commercialization journey. We prioritize collaborations with partners who share our vision for transformation. Ready to explore partnership opportunities? Connect with us at BIO and learn more about our active areas of interest and how we can collaborate to accelerate breakthrough innovations that improve patients' lives worldwide.